Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Review
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,150 | Dovepress* | 6,012+ | 485 | 6,497 | |
| PubMed Central* | 1,138 | 202 | 1,340 | ||
| Totals | 7,150 | 687 | 7,837 | ||
| *Since 14 July 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar